The CB(1) antagonist rimonabant is adjunctively therapeutic as well as monotherapeutic in an animal model of Parkinson's disease. (Q46026291)
Jump to navigation
Jump to search
scientific article published on 3 May 2009
- The CB1 antagonist rimonabant is adjunctively therapeutic as well as monotherapeutic in an animal model of Parkinson's disease
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The CB(1) antagonist rimonabant is adjunctively therapeutic as well as monotherapeutic in an animal model of Parkinson's disease. |
scientific article published on 3 May 2009 |
|
Statements
1 reference
The CB(1) antagonist rimonabant is adjunctively therapeutic as well as monotherapeutic in an animal model of Parkinson's disease. (English)
1 reference
J E Kelsey
1 reference
O Harris
1 reference
J Cassin
1 reference
3 May 2009
1 reference
203
1 reference
2
1 reference
304-307
1 reference
Identifiers
1 reference